Mirae Asset Global Investments’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,572
| Closed | -$9.65K | – | 1692 |
|
|
2024
Q3 | $9.65K | Buy |
2,572
+452
| +21% | +$1.7K | ﹤0.01% | 1500 |
|
|
2024
Q2 | $8.9K | Sell |
2,120
-29,467
| -93% | -$124K | ﹤0.01% | 1468 |
|
|
2024
Q1 | $522K | Sell |
31,587
-8,987
| -22% | -$148K | ﹤0.01% | 1878 |
|
|
2023
Q4 | $615K | Buy |
40,574
+5,917
| +17% | +$89.6K | ﹤0.01% | 1868 |
|
|
2023
Q3 | $695K | Buy |
34,657
+4,253
| +14% | +$85.3K | ﹤0.01% | 1724 |
|
|
2023
Q2 | $857K | Buy |
30,404
+569
| +2% | +$16K | ﹤0.01% | 1657 |
|
|
2023
Q1 | $513K | Buy |
29,835
+7,914
| +36% | +$136K | ﹤0.01% | 1906 |
|
|
2022
Q4 | $441K | Buy |
21,921
+4,515
| +26% | +$90.9K | ﹤0.01% | 1959 |
|
|
2022
Q3 | $377K | Buy |
17,406
+4,899
| +39% | +$106K | ﹤0.01% | 2040 |
|
|
2022
Q2 | $352K | Buy |
+12,507
| New | +$352K | ﹤0.01% | 1910 |
|